Trial · NCT02914275
Results by group130
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 130
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Seqirus QIV | A/H1N1 | 370.0 | 95% Confidence Interval 345.13 to 396.55 | Geometric Mean Titer |
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Comparator QIV | A/H1N1 | 311.7 | 95% Confidence Interval 276.88 to 350.90 | Geometric Mean Titer |
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Seqirus QIV | A/H3N2 | 436.8 | 95% Confidence Interval 403.04 to 473.28 | Geometric Mean Titer |
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Comparator QIV | A/H3N2 | 589.1 | 95% Confidence Interval 516.42 to 671.91 | Geometric Mean Titer |
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Seqirus QIV | B/YAM | 25.5 | 95% Confidence Interval 23.93 to 27.06 | Geometric Mean Titer |
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Comparator QIV | B/YAM | 29.7 | 95% Confidence Interval 26.51 to 33.21 | Geometric Mean Titer |
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Seqirus QIV | B/VIC | 56.8 | 95% Confidence Interval 52.90 to 60.96 | Geometric Mean Titer |
| The Geometric Mean Titer (GMT) Ratio of Each Virus Strain. | Comparator QIV | B/VIC | 57.9 | 95% Confidence Interval 51.04 to 65.62 | Geometric Mean Titer |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Seqirus QIV | A/H1N1 | 79.1 | 95% Confidence Interval 76.9 to 81.1 | Percentage of participants |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Comparator QIV | A/H1N1 | 68.8 | 95% Confidence Interval 64.5 to 72.9 | Percentage of participants |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Seqirus QIV | A/H3N2 | 82.3 | 95% Confidence Interval 80.2 to 84.2 | Percentage of participants |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Comparator QIV | A/H3N2 | 84.9 | 95% Confidence Interval 81.4 to 88.0 | Percentage of participants |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Seqirus QIV | B/YAM | 38.9 | 95% Confidence Interval 36.4 to 41.4 | Percentage of participants |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Comparator QIV | B/YAM | 41.9 | 95% Confidence Interval 37.5 to 46.5 | Percentage of participants |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Seqirus QIV | B/VIC | 60.2 | 95% Confidence Interval 57.6 to 62.7 | Percentage of participants |
| The Difference in Seroconversion Rate (SCR) for Each Virus Strain. | Comparator QIV | B/VIC | 61.1 | 95% Confidence Interval 56.6 to 65.4 | Percentage of participants |
| Number of Participants With Solicited Local Adverse Reactions and Solicited Systemic Adverse Events (AE) | Seqirus QIV | Solicited AEs, Any | 940 | Participants | |
| Number of Participants With Solicited Local Adverse Reactions and Solicited Systemic Adverse Events (AE) | Comparator QIV | Solicited AEs, Any | 312 | Participants | |
| Number of Participants With Solicited Local Adverse Reactions and Solicited Systemic Adverse Events (AE) | Seqirus QIV | Solicited AEs, Grade 1 | 592 | Participants | |
| Number of Participants With Solicited Local Adverse Reactions and Solicited Systemic Adverse Events (AE) | Comparator QIV | Solicited AEs, Grade 1 | 189 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02914275/results